Raniya Khadiullina
Overview
Explore the profile of Raniya Khadiullina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
142
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davidovich P, Nikolaev D, Khadiullina R, Gurzhiy V, Bulatov E
Bioorg Med Chem Lett
. 2024 Dec;
117():130058.
PMID: 39644937
The NRF2 transcriptional factor is a member of cellular stress response machinery and is activated in response to oxidative stress caused either by cellular homeostasis imbalance or by environmental challenges....
2.
Chasov V, Davletshin D, Gilyazova E, Mirgayazova R, Kudriaeva A, Khadiullina R, et al.
J Biomed Res
. 2024 May;
38(3):222-232.
PMID: 38738269
The tumor suppressor p53 is a transcription factor with a powerful antitumor activity that is controlled by its negative regulator murine double minute 2 (MDM2, also termed HDM2 in humans)...
3.
Khadiullina R, Mirgayazova R, Davletshin D, Khusainova E, Chasov V, Bulatov E
Life (Basel)
. 2023 Jan;
13(1).
PMID: 36675980
The p53 protein is a transcription factor that preserves the integrity of the genome. The gene has inactivating mutations in about 50% of all human cancers. Some missense mutations lead...
4.
Stephenson Clarke J, Douglas L, Duriez P, Balourdas D, Joerger A, Khadiullina R, et al.
ACS Pharmacol Transl Sci
. 2022 Nov;
5(11):1169-1180.
PMID: 36407959
The tumor suppressor protein p53 is inactivated in the majority of human cancers and remains a prime target for developing new drugs to reactivate its tumor suppressing activity for anticancer...
5.
Chasov V, Zaripov M, Mirgayazova R, Khadiullina R, Zmievskaya E, Ganeeva I, et al.
Front Immunol
. 2021 Sep;
12:707734.
PMID: 34484205
Transcription factor and oncosuppressor protein p53 is considered as one of the most promising molecular targets that remains a high-hanging fruit in cancer therapy. gene encoding the p53 protein is...
6.
Chasov V, Mirgayazova R, Zmievskaya E, Khadiullina R, Valiullina A, Stephenson Clarke J, et al.
Front Oncol
. 2020 Sep;
10:1460.
PMID: 32974171
The transcription factor p53 is a key tumor suppressor that is inactivated in almost all cancers due to either point mutations in the gene or overexpression of its negative regulators....
7.
Mirgayazova R, Khadiullina R, Chasov V, Mingaleeva R, Miftakhova R, Rizvanov A, et al.
Genes (Basel)
. 2020 Jul;
11(6).
PMID: 32630614
The gene encodes the transcription factor and oncosuppressor p53 protein that regulates a multitude of intracellular metabolic pathways involved in DNA damage repair, cell cycle arrest, apoptosis, and senescence. In...
8.
Mirgayazova R, Khadiullina R, Mingaleeva R, Chasov V, Gomzikova M, Garanina E, et al.
Mol Biol Res Commun
. 2020 Jan;
8(3):119-128.
PMID: 31998813
Bioinorganic medicinal chemistry remains a hot field for research aimed at developing novel anti-cancer treatments. Discovery of metal complexes as potent antitumor chemotherapeutics such as cisplatin led to a significant...